Antimalarial activity of the novel quinoline/6-thiopurine conjugate in Gallus gallus Linnaeus, infected experimentally by Plasmodium (Novyella) juxtanucleare

Chem Biol Drug Des. 2009 Oct;74(4):434-7. doi: 10.1111/j.1747-0285.2009.00877.x. Epub 2009 Aug 19.

Abstract

This study aimed to evaluate the 4-(6'-thiopurine)-7-chloroquinoline, a novel quinoline/6-thiopurine conjugate, for the treatment of Gallus gallus experimentally infected with Plasmodium juxtanucleare, an avian malaria agent. The avian group treated with 4-(6'-thiopurine)-7-chloroquinoline showed a significative parasite clearance and maintained a low level of parasitaemia, when compared with the untreated control group and to the chloroquine treated avian group.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antimalarials / chemical synthesis
  • Antimalarials / chemistry
  • Antimalarials / pharmacology*
  • Chickens
  • Chloroquine / chemistry
  • Chloroquine / pharmacology
  • Disease Models, Animal
  • Malaria, Avian / drug therapy
  • Parasitemia / drug therapy
  • Plasmodium / drug effects*
  • Purines / chemical synthesis
  • Purines / chemistry
  • Purines / pharmacology*
  • Quinolines / chemical synthesis
  • Quinolines / chemistry
  • Quinolines / pharmacology*

Substances

  • 4-(6'-thiopurine)-7-chloroquinoline
  • Antimalarials
  • Purines
  • Quinolines
  • Chloroquine